<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240205060913N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-07-31</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Atrial Fibrillation-Specific Cognitive Behavioral Therapy (AF-CBT) and Stress Management and Resiliency Training (SMART) in Patients with Atrial Fibrillation</public_title>
      <acronym></acronym>
      <scientific_title>Comparative Effectiveness of Atrial Fibrillation-Specific Cognitive Behavioral Therapy (AF-CBT) and Stress Management and Resiliency Training (SMART) on Perceived Stress, Psychological Resilience, Quality of Life, and Sleep Quality in Patients with Atrial Fibrillation: A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-08-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>141</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84988</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Patients enrolled in the study will be randomly assigned in a 1:1:1 ratio to one of three groups: “Cognitive Behavioral Therapy for Atrial Fibrillation (AF-CBT)”, “Stress Management and Resilience Training (SMART)”, and the control group. The randomization process was performed through a random number generator. An independent research assistant who will not be involved in data collection will use the Research Randomizer software (http://www.randomizer.org) to generate the random number list. A total of 141 papers, 47 of which will be printed with the number 1, 47 with the number 2, and the last 47 with the number 3 (1, 2, and 3 representing the intervention and control groups, respectively), will be sealed in an envelope that will only be accessible by the research assistant at the time of randomization, Blinding description: Due to the nature of the treatment, patients and therapists were aware of the group assignment, and only the statistician would be unaware of the group assignment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Atrial fibrillation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Atrial fibrillation (AF)-specific exposure-based cognitive behavioral therapy will be delivered entirely over the Internet using a secure, personalized web-based platform. The intervention will be therapist-led, will last 10 weeks, and will consist of 5 interactive modules with weekly assignments to be completed in the first 5 weeks. The modules will be downloadable as PDF files. After completing the fifth module, participants will continue to work with the treatment content for the remaining 5 weeks and will submit weekly reports of their exposure exercises to the therapist. Participants will be asked to spend approximately 30–60 min per day studying and practicing the treatment content. The treatment will primarily address two processes that perpetuate disability in atrial fibrillation (30, 41): hypervigilance and fear of AF symptoms, and avoidance of physical and social activities. Treatment interventions will include: education about atrial fibrillation (pathophysiology and drug therapy) and heightened attention to symptoms; self-monitoring practice (awareness of current cardiac symptoms, thoughts, feelings, and behavioral motivations) to reduce the negative value of symptoms; exposure to physical sensations similar to AF symptoms by performing a series of physical exercises, such as walking up and down stairs to increase heart rate or inducing dizziness or shortness of breath with hyperventilation, to reduce fear and hypervigilance of symptoms; exposure to real-life situations with conditions or activities that are usually avoided (such as participating in a social activity while experiencing cardiac symptoms); reduction or elimination of behaviors such as delaying pulse checking that would be used to control symptoms. Behavioral activation, which is encouraging patients to take action toward important life goals that are disrupted by AF; focus on preventing relapse and managing potential progression. Intervention 2: Intervention group 2: The SMART program is a structured psycho-educational intervention that teaches participants a variety of skills to cope more effectively with stress and reduce its negative effects on health. The program includes training in mind-body skills (meditation techniques, brief relaxations, mindfulness, and yoga), stress awareness tools, healthy lifestyle behaviors (sleep, exercise, nutrition, and social support), and cognitive restructuring and adaptive coping skills (modeled after cognitive-behavioral therapy, acceptance and commitment therapy, and positive psychology). The program will meet once a week for 1.5 hours for eight weeks and will include lecture segments, experiential exercises, and small group activities. As part of the program, participants will receive a workbook and audio-guided meditation files and will be encouraged to practice for 10–20 minutes daily and keep a daily journal of their practices (37). Although many of the tools learned in the program are designed to be integrated into daily life, participants are asked to use one of the program’s brief relaxations if they experience cardiac symptoms (such as palpitations) as a way to reduce automatic dissonance and associated anxiety. All SMART group sessions will be held online via a secure, approved videoconferencing platform that allows for encrypted transmission of audio and video, and will be led by a faculty member experienced in leading these groups. Sessions will be held in the evenings on weekdays. The study’s research coordinator will assist each participant in installing the required software and familiarizing them with how to connect and use the virtual environment prior to the first session. Intervention 3: Control group: The control group will receive the same routine training as each center, which includes patient education by nurses, educational pamphlets, and educational follow-ups by the ward nurse.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information available.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Neda Sanaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Valiasr St., Niayesh Insersection, Nursing and Midwifery Faculty</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>nedasanaie@ymail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Neda Sanaie</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Vali Asr St., intersection of Ayat A... Hashemi Rafsanjani Highway, in front of Heart Hospital</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>nedasanaie@ymail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 18 years or older.
Diagnosis of atrial fibrillation based on ECG
CHA₂DS₂-VASc score of 1 or greater in men and 2 or greater in women.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with severe complications of their current disease
atrial fibrillation immediately after thoracic surgery
acute pulmonary embolism
known hyperthyroidism
malignant disease with a prognosis of survival of less than one year or a diagnosis of terminal illness
cognitive impairment and psychiatric disorder
receiving regular psychotherapy for a psychiatric disorder
participation in another study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Atrial fibrillation (AF)-specific exposure-based cognitive behavioral therapy will be delivered entirely over the Internet using a secure, personalized web-based platform. The intervention will be therapist-led, will last 10 weeks, and will consist of 5 interactive modules with weekly assignments to be completed in the first 5 weeks. The modules will be downloadable as PDF files. After completing the fifth module, participants will continue to work with the treatment content for the remaining 5 weeks and will submit weekly reports of their exposure exercises to the therapist. Participants will be asked to spend approximately 30–60 min per day studying and practicing the treatment content. The treatment will primarily address two processes that perpetuate disability in atrial fibrillation (30, 41): hypervigilance and fear of AF symptoms, and avoidance of physical and social activities. Treatment interventions will include: education about atrial fibrillation (pathophysiology and drug therapy) and heightened attention to symptoms; self-monitoring practice (awareness of current cardiac symptoms, thoughts, feelings, and behavioral motivations) to reduce the negative value of symptoms; exposure to physical sensations similar to AF symptoms by performing a series of physical exercises, such as walking up and down stairs to increase heart rate or inducing dizziness or shortness of breath with hyperventilation, to reduce fear and hypervigilance of symptoms; exposure to real-life situations with conditions or activities that are usually avoided (such as participating in a social activity while experiencing cardiac symptoms); reduction or elimination of behaviors such as delaying pulse checking that would be used to control symptoms. Behavioral activation, which is encouraging patients to take action toward important life goals that are disrupted by AF; focus on preventing relapse and managing potential progression.</i_keyword>
      <i_keyword>Intervention group 2: The SMART program is a structured psycho-educational intervention that teaches participants a variety of skills to cope more effectively with stress and reduce its negative effects on health. The program includes training in mind-body skills (meditation techniques, brief relaxations, mindfulness, and yoga), stress awareness tools, healthy lifestyle behaviors (sleep, exercise, nutrition, and social support), and cognitive restructuring and adaptive coping skills (modeled after cognitive-behavioral therapy, acceptance and commitment therapy, and positive psychology). The program will meet once a week for 1.5 hours for eight weeks and will include lecture segments, experiential exercises, and small group activities. As part of the program, participants will receive a workbook and audio-guided meditation files and will be encouraged to practice for 10–20 minutes daily and keep a daily journal of their practices (37). Although many of the tools learned in the program are designed to be integrated into daily life, participants are asked to use one of the program’s brief relaxations if they experience cardiac symptoms (such as palpitations) as a way to reduce automatic dissonance and associated anxiety. All SMART group sessions will be held online via a secure, approved videoconferencing platform that allows for encrypted transmission of audio and video, and will be led by a faculty member experienced in leading these groups. Sessions will be held in the evenings on weekdays. The study’s research coordinator will assist each participant in installing the required software and familiarizing them with how to connect and use the virtual environment prior to the first session.</i_keyword>
      <i_keyword>Control group: The control group will receive the same routine training as each center, which includes patient education by nurses, educational pamphlets, and educational follow-ups by the ward nurse.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Perceived stress: In this study, perceived stress refers to the score obtained from perceived stress. Timepoint: Before and immediately after the intervention and 3 months after the intervention. Method of measurement: PSS-10 – Perceived Stress Scale.</prim_outcome>
      <prim_outcome>Atrial fibrillation-specific quality of life: In this study, atrial fibrillation-related quality of life refers to the average score obtained from the Atrial Fibrillation Impact on Quality of Life Questionnaire. Timepoint: Before and immediately after the intervention and 3 months after the intervention. Method of measurement: AFEQT – Atrial Fibrillation Effect on Quality-of-Life.</prim_outcome>
      <prim_outcome>Sleep Quality. Timepoint: Before and immediately after the intervention and 3 months after the intervention. Method of measurement: PSQI – Pittsburgh Sleep Quality Index.</prim_outcome>
      <prim_outcome>Psychological resilience. Timepoint: Before and immediately after the intervention and 3 months after the intervention. Method of measurement: CD-RISC – Connor-Davidson Resilience Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-07-21</approval_date>
        <contact_name>Faculties of Pharmacy, Nursing and Midwifery - Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Tehran, Vali Asr St., intersection of Ayat A... Hashemi Rafsanjani Highway, in front of Heart Hospital Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
